News

Highlights about our research, team members and events

Second ATTACK Symposium successfully held in Freinsheim/Germany

The second joint symposium of the ATTACK consortium was held October 22-25, 20223 in the Landhotel Altes Wasserwerk in Freinsheim, Germany. After the registration of participants and a conference dinner on Sunday evening, the meeting proceeded with several talk- and...

First ATTACK Symposium successfully held in Oxford/UK

From October 28-29, 2022, our first Symposium took place at the The Kennedy Institute of Rheumatology (KIR) at the University of Oxford. We would like to sincerely thank all participants, especially our external guest scientists Kiera L Clayton (Dept. of Pathology,...

Visit of ATTACK PIs in Homburg

Two of our PIs (Salvatore Valitutti and Michael Dustin) visited the Saarland University in June 2022 as invited speakers within the frame of the symposium of the Collaborative Research Center 894 on cutting edge concepts in calcium signaling. During their stays in...

Interview of Chiara Cassioli on her ATTACK project

In her ATTACK-related project, our team member Chiara Cassioli (postdoctoral researcher in the lab of Cosima Baldari at the University of Siena) is trying to figure out what trafficking pathways are responsible for the biogenesis and the release of SupraMolecular...

New insights into the body’s own defense against tumor cells

240,000 people die of cancer in Germany every year. It is therefore of great importance to investigate the body’s own defense strategies against cancer cells in order to enable new therapies. Our international research team from Homburg, Oxford, Siena and Toulouse as...

ATTACK Homepage online

We are pleased to present the ATTACK homepage, available via this link: https://www.supramolecular-attack-particles.eu and hope it will give you a detailed overview of the research, the people behind the ERC Synergy grant and the range of activities. Enjoy reading!

Official Start of „ATTACK“

Within the framework of this ERC Synergy Grant, a team of about 40 scientists from Germany, Italy, UK and France will research the latest approaches in the fight against cancer cells. The goal of the project is the development of a new biotechnology around...